
NEW INVESTIGATIONAL CLINICAL STUDY USING A NEUFLO SYSTEM TO TREAT URINARY SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH)
Who can join?
- Men aged 45 or older
- Men not satisfied with their current treatment for BPH
- Men who are able to attend regular check-ups with the study doctors
What to expect
This study involves an approx. 30 min procedure performed by a certified urologist. All participants enrolled in the study will receive a one-off treatment with the Neuflo System. The purpose of this study is to evaluate the safety and performance of the Neuflo System in relieving urinary symptoms secondary to Benign Prostatic Hyperplasia (BPH).
- The study doctor will explain the possible risks and benefits involved with your participation.
- There is no cost to participate in this study, undergo the procedure, or attend study-related visits.
- Attend 5 to 6 post-procedure follow up visits over 12 months

CONTACT INFORMATION
UROLOGY CLINIC
Urology BOP
Suite 6, Level 1,
850 Cameron Road,
Tauranga 3112, NZ
PRINCIPAL INVESTIGATOR
Dr Peter Gilling
CONTACT DETAILS
Name: Margaret Ross
Email: marg@urobop.co.nz
Phone: (07) 577 7795
The Sponsor of this study is Prostacare Pty Ltd.
Neuflo Advertisement Version 1.0 07 Sep 2023